Filing Flows › Schrodinger (SDGR) › Q2 2026 › vs Q2 2025
Schrodinger (SDGR) Q2 2026 vs Q2 2025 (year over year)
Schrodinger's revenue rose $4.1M (+8%) from $54.8M in Q2 2025 to $58.9M in Q2 2026. The biggest changes: Drug discovery +$9.0M (+65%); On-premise software −$6.4M (-41%); Hosted software +$4.0M (+36%).
Schrodinger, Q2 2026: revenue $58.9M (+8% year over year), operating margin -70.6%, net earnings $6.0M, operating cash flow −$34.1M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Drug discovery | $23.0M | $13.9M | $9.0M | +65% |
| Hosted software | $15.2M | $11.1M | $4.0M | +36% |
| On-premise software | $9.3M | $15.7M | −$6.4M | -41% |
| Software maintenance | $4.9M | $6.8M | −$1.9M | -28% |
| Contribution | $3.4M | $4.8M | −$1.4M | -30% |
| Software contribution | $2.9M | $4.5M | −$1.6M | -35% |
| Drug discovery contribution | $438K | $275K | $163K | +59% |
| Revenue | $58.9M | $54.8M | $4.1M | +8% |
| Other income, net | $48.9M | $10.0M | $38.9M | +388% |
| Costs & expenses | $108M | $108M | −$166K | -0.2% |
| Operating costs | $100M | $108M | −$7.2M | -7% |
| Income tax | $1.4M | $287K | $1.1M | +378% |
| Net earnings | $6.0M | −$43.2M | $49.1M | — |
| Cost of revenue | $26.5M | $28.6M | −$2.1M | -7% |
| Research & development | $41.0M | $43.1M | −$2.1M | -5% |
| Sales & marketing | $10.3M | $10.7M | −$468K | -4% |
| General & admin | $22.7M | $25.2M | −$2.5M | -10% |
| Operating cash sources | $50.3M | $21.2M | $29.1M | +138% |
| Depreciation & amortization | $1.5M | $1.5M | −$43K | -3% |
| Share-based compensation | $8.8M | $10.6M | −$1.8M | -17% |
| Cash used in operations | $34.1M | $52.2M | −$18.1M | -35% |
| Working capital & other | $50.3M | $21.2M | $29.1M | +138% |
Questions
How much did Schrodinger's revenue grow year over year in Q2 2026?
Schrodinger's revenue rose $4.1M (+8%) from $54.8M in Q2 2025 to $58.9M in Q2 2026.
What drove Schrodinger's revenue change in Q2 2026?
Drug discovery +$9.0M (+65%); On-premise software −$6.4M (-41%); Hosted software +$4.0M (+36%).